Related Experiment Videos
Circulating anticoagulant associated with chronic active hepatitis
Southern Medical Journal
|October 1, 1978
Summary
Patients with chronic active hepatitis may develop circulating anticoagulants targeting factors XI and XII. This finding necessitates caution and consideration of bleeding risks, especially before invasive procedures like liver biopsy.
Area of Science:
- Hepatology
- Hematology
- Immunology
Background:
- Chronic active hepatitis often presents with diverse serologic abnormalities.
- Understanding these abnormalities is crucial for patient management and risk assessment.
Observation:
- A case of chronic active hepatitis is presented in a patient with a circulating anticoagulant.
- This anticoagulant specifically targets coagulation factors XI and XII.
Findings:
- The presence of circulating anticoagulants should be suspected in chronic active hepatitis patients exhibiting a prolonged partial thromboplastin time.
- This specific anticoagulant complication is associated with factors XI and XII.
Implications:
- The risk associated with liver biopsy in these patients remains uncharacterized.
- Healthcare providers must consider this potential bleeding hazard in all chronic active hepatitis patients, particularly those with prolonged partial thromboplastin time.